These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23711143)

  • 21. Comparative Study on the Antivirus Activity of Shuang-Huang-Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro.
    Ma Q; Liang D; Song S; Yu Q; Shi C; Xing X; Luo JB
    Viruses; 2017 Apr; 9(4):. PubMed ID: 28417913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.
    Zhang Y; Jamaluddin M; Wang S; Tian B; Garofalo RP; Casola A; Brasier AR
    J Virol; 2003 May; 77(10):5933-47. PubMed ID: 12719586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heme Oxygenase-1 Modulates Human Respiratory Syncytial Virus Replication and Lung Pathogenesis during Infection.
    Espinoza JA; León MA; Céspedes PF; Gómez RS; Canedo-Marroquín G; Riquelme SA; Salazar-Echegarai FJ; Blancou P; Simon T; Anegon I; Lay MK; González PA; Riedel CA; Bueno SM; Kalergis AM
    J Immunol; 2017 Jul; 199(1):212-223. PubMed ID: 28566367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of a lethal aged mouse model of human respiratory syncytial virus infection.
    Zhang K; Li C; Luo YS; Wen L; Yuan S; Wang D; Ho-Yin Wong B; Zhao X; Chiu MC; Ye ZW; Sun Z; Zhao H; Zhang X; Hu M; Yang D; Shuai H; Wang Y; He J; Bose ME; Henrickson KJ; Huang JD; Zheng B; Chu H; Zhou J
    Antiviral Res; 2019 Jan; 161():125-133. PubMed ID: 30503888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.
    Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM
    Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.
    Dunn MC; Knight DA; Waldman WJ
    Antivir Ther; 2011; 16(3):309-17. PubMed ID: 21555813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different types of effective fractions from Radix Isatidis revealed a multiple-target synergy effect against respiratory syncytial virus through RIG-I and MDA5 signaling pathways, a pilot study to testify the theory of superposition of traditional Chinese Medicine efficacy.
    Xu H; He L; Chen J; Hou X; Fan F; Wu H; Zhu H; Guo Y
    J Ethnopharmacol; 2019 Jul; 239():111901. PubMed ID: 31051218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of extract from Paeonia lactiflora and Astragalus membranaceus against liver injury induced by bacillus Calmette-Guérin and lipopolysaccharide in mice.
    Sun WY; Wei W; Gui SY; Wu L; Wang H
    Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):143-9. PubMed ID: 18816297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two novel fusion inhibitors of human respiratory syncytial virus.
    Lundin A; Bergström T; Bendrioua L; Kann N; Adamiak B; Trybala E
    Antiviral Res; 2010 Dec; 88(3):317-24. PubMed ID: 20965215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.
    Lee BH; Chathuranga K; Uddin MB; Weeratunga P; Kim MS; Cho WK; Kim HI; Ma JY; Lee JS
    J Microbiol; 2017 Jun; 55(6):488-498. PubMed ID: 28551874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
    Blockus S; Sake SM; Wetzke M; Grethe C; Graalmann T; Pils M; Le Goffic R; Galloux M; Prochnow H; Rox K; Hüttel S; Rupcic Z; Wiegmann B; Dijkman R; Rameix-Welti MA; Eléouët JF; Duprex WP; Thiel V; Hansen G; Brönstrup M; Haid S; Pietschmann T
    Antiviral Res; 2020 May; 177():104774. PubMed ID: 32197980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory Syncytial Virus: pathology, therapeutic drugs and prophylaxis.
    Gomez RS; Guisle-Marsollier I; Bohmwald K; Bueno SM; Kalergis AM
    Immunol Lett; 2014 Nov; 162(1 Pt A):237-47. PubMed ID: 25268876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory damage on respiratory and nervous systems due to hRSV infection.
    Bohmwald K; Espinoza JA; Becerra D; Rivera K; Lay MK; Bueno SM; Riedel CA; Kalergis AM
    Curr Opin Immunol; 2015 Oct; 36():14-21. PubMed ID: 26026788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzimidazole analogs inhibit respiratory syncytial virus G protein function.
    Evans CW; Atkins C; Pathak A; Gilbert BE; Noah JW
    Antiviral Res; 2015 Sep; 121():31-8. PubMed ID: 26116756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
    Rahman F; Libre C; Oleinikov A; Tcherniuk S
    J Gen Virol; 2021 Aug; 102(8):. PubMed ID: 34342560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prospects For the Use of Peptides against Respiratory Syncytial Virus].
    Shilovskiy IP; Andreev SM; Kozhikhova KV; Nikolskii AA; Khaitov MR
    Mol Biol (Mosk); 2019; 53(4):541-560. PubMed ID: 31397431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinoviruses.
    Ngan LT; Jang MJ; Kwon MJ; Ahn YJ
    PLoS One; 2015; 10(4):e0121629. PubMed ID: 25860871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quercetin pentaacetate inhibits in vitro human respiratory syncytial virus adhesion.
    Lopes BRP; da Costa MF; Genova Ribeiro A; da Silva TF; Lima CS; Caruso IP; de Araujo GC; Kubo LH; Iacovelli F; Falconi M; Desideri A; de Oliveira J; Regasini LO; de Souza FP; Toledo KA
    Virus Res; 2020 Jan; 276():197805. PubMed ID: 31712123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
    Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.